What is the recommended starting dose of cannabis for fibromyalgia?

PostedFebruary 17, 2026

UpdatedFebruary 17, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Determining the right cannabis dosage for managing fibromyalgia can be challenging, especially for first-time users. While there’s no universal prescription, many clinicians suggest a cautious, individualised approach to fibromyalgia treatment using cannabis therapy.

A “start low and go slow” method is often recommended to reduce unwanted side effects and better track symptom responses.

Key considerations for establishing a starting dose

Below are important aspects patients and practitioners consider when starting cannabis therapy:

THC vs CBD Ratios

Begin with CBD-dominant strains or oils to gauge tolerance. CBD is non-psychoactive and well-tolerated, while THC can cause dizziness or anxiety in new users.

Initial Milligram Range

A typical starting cannabis dosage might be 2.5 mg of THC or CBD once daily. This can be gradually increased over days or weeks based on effectiveness.

Form of Administration

Oils and tinctures allow precise dosing and are commonly used in fibromyalgia treatment. Inhaled forms may act faster but can be harder to dose accurately.

Timing Strategy

Patients often start cannabis therapy in the evening to minimise interference with daily tasks, adjusting to morning or split doses depending on symptoms.

Medical Oversight

Always begin under medical supervision, especially when combining with other medications. Adjustments to the starting dose should follow observed responses.

In summary, finding the right cannabis dosage for fibromyalgia treatment requires personalisation and patience, ideally under clinical guidance.

If you’re exploring cannabis treatment options for fibromyalgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Fibromyalgia.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.